suprane- desflurane liquid
general injectables & vaccines, inc - desflurane (unii: crs35bz94q) (desflurane - unii:crs35bz94q) - desflurane 240 ml in 240 ml - 1.1 induction of anesthesia suprane is indicated as an inhalation agent for induction of anesthesia for inpatient and outpatient surgery in adults. suprane is contraindicated as an inhalation agent for the induction of anesthesia in pediatric patients because of a high incidence of moderate to severe upper airway adverse events. 1.2 maintenance of anesthesia suprane is indicated as an inhalation agent for maintenance of anesthesia for inpatient and outpatient surgery in adults and in pediatric patients. after induction of anesthesia with agents other than suprane, and tracheal intubation, suprane is indicated for maintenance of anesthesia in infants and children. suprane is not approved for maintenance of anesthesia in non-intubated children due to an increased incidence of respiratory adverse reactions, including coughing, laryngospasm, and secretions [see warnings and precautions (5.3) and clinical studies (14.5)]. suprane (desflurane, usp) is indicated as an inhalation agent for induction of anesthesia f
suprane- desflurane liquid
henry schein, inc. - desflurane (unii: crs35bz94q) (desflurane - unii:crs35bz94q) - 1.1 induction of anesthesia suprane is indicated as an inhalation agent for induction of anesthesia for inpatient and outpatient surgery in adults. suprane is contraindicated as an inhalation agent for the induction of anesthesia in pediatric patients because of a high incidence of moderate to severe upper airway adverse events. 1.2 maintenance of anesthesia suprane is indicated as an inhalation agent for maintenance of anesthesia for inpatient and outpatient surgery in adults and in pediatric patients. after induction of anesthesia with agents other than suprane, and tracheal intubation, suprane is indicated for maintenance of anesthesia in infants and children. suprane is not approved for maintenance of anesthesia in non-intubated children due to an increased incidence of respiratory adverse reactions, including coughing, laryngospasm, and secretions [see warnings and precautions (5.3) and clinical studies (14.5)]. suprane (desflurane, usp) is indicated as an inhalation agent for induction of anesthesia f
alapren 10 tablets
ranbaxy -
alapren 2,5 tablets
ranbaxy -
alapren 20 tablets
ranbaxy -
alapren 5 tablets
ranbaxy -
hr-enalapril maleate
hexal -
pharmapress 10 mg tablet
lennon -
pharmapress 20 mg tablet
lennon -
sevorane
abbvie limited - sevoflurane 100% - volatile liquid for inhalation - 100 % - active: sevoflurane 100%